Bacteriolytic therapy with Clostridium ghonii for experimental solid tumors

Area of Science:

• Oncology
• Microbiology
• Bacteriotherapy

Background:

• Clostridium ghonii (C. ghonii) is a non-pathogenic, anaerobic, spore-forming bacterium.
• The potential of C. ghonii for bacterial oncolysis has not been previously investigated.
• Solid tumors remain a significant challenge in cancer treatment.

Purpose of the Study:

• To evaluate the bacterial oncolytic capability of C. ghonii for treating experimental solid tumors.
• To assess the therapeutic potential of C. ghonii as a novel bacteriolytic agent.

Main Methods:

• In vitro analysis of C. ghonii's effect on cultured A549 cells, including apoptosis and necrosis.
• Intratumoral injection of C. ghonii spores into tumor-bearing mice.
• Assessment of tumor volume, necrosis, and immune response post-injection.
• Evaluation of combination therapy with radiation and C. ghonii.

Main Results:

• C. ghonii secreted collagenase IV and phospholipase C, inducing apoptosis and necrosis in A549 cells.
• C. ghonii spores germinated within tumors, triggering immune responses in mice.
• Intratumoral injection of C. ghonii spores significantly reduced tumor volumes and increased necrosis.
• Combination therapy with radiation and C. ghonii showed additive anti-tumor effects.

Conclusions:

• C. ghonii exhibits significant bacteriolytic and anti-tumor properties against solid tumors.
• C. ghonii demonstrates potential as a safe and effective novel bacteriolytic therapy for solid tumors.
• The combination of C. ghonii with conventional therapies like radiation may enhance treatment efficacy.